BioCentury | Jan 8, 2020
Clinical News

Apellis readies to compete with Soliris in PNH based on Phase III data

...Therapy (FACIT)-Fatigue scores by 9.2 points vs. -2.7 points for Soliris. “A three-point change in FACIT...
BioCentury | Nov 23, 2019
Clinical News

A first-in-class approval for rare anemia could be next step for Sanofi’s sutimlimab

...normal concentrations of about 20 μM and improved mean Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
BioCentury | Apr 2, 2019
Financial News

Fusion raises $105M series B for radiopharmaceutical pipeline

...Johnson & Johnson Innovation -- JJDC Inc., TPG Biotech, Seroba Life Sciences, Genesys Capital and FACIT...
BioCentury | Feb 1, 2019
Company News

Celgene gains option for Triphase's epigenetic cancer therapy

...leukemia rearrangements leukemia and lymphoma, FACIT President David O'Neill told BioCentury. Triphase is majority-owned by FACIT...
BioCentury | Jan 29, 2019
Company News

Celgene gains option for Triphase's epigenetic cancer therapy

...leukemia rearrangements leukemia and lymphoma, FACIT President David O'Neill told BioCentury. Triphase is majority-owned by FACIT...
BioCentury | Dec 21, 2018
Clinical News

Achillion discontinuing PNH monotherapy

...said ACH-4471 monotherapy led to increases in hemoglobin and Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
...inhibitor Indication: Treat paroxysmal nocturnal hemoglobinuria (PNH) Endpoint: Hemoglobin, Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
BioCentury | Dec 19, 2018
Clinical News

Achillion down after discontinuing PNH monotherapy

...said ACH-4471 monotherapy led to increases in hemoglobin and Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
BioCentury | Jun 22, 2018
Politics & Policy

FDA lays out cancer PRO strategy

...of the Common Technology Criteria for Adverse events (CTCAE), Functional Assessment of Chronic Illness Therapy (FACIT...
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Johnson, Isogenica Ltd. Number of employees: 20 Funds raised: $46 million Investors: Adams Street Partners, FACIT...
BioCentury | Apr 27, 2018
Clinical News

Alexion's long-acting C5 inhibitor meets in Phase III switch trial

...hemolysis (0% vs. 5.1%); the change from baseline in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
...of patients with breakthrough hemolysis, change from baseline in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
Items per page:
1 - 10 of 67
BioCentury | Jan 8, 2020
Clinical News

Apellis readies to compete with Soliris in PNH based on Phase III data

...Therapy (FACIT)-Fatigue scores by 9.2 points vs. -2.7 points for Soliris. “A three-point change in FACIT...
BioCentury | Nov 23, 2019
Clinical News

A first-in-class approval for rare anemia could be next step for Sanofi’s sutimlimab

...normal concentrations of about 20 μM and improved mean Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
BioCentury | Apr 2, 2019
Financial News

Fusion raises $105M series B for radiopharmaceutical pipeline

...Johnson & Johnson Innovation -- JJDC Inc., TPG Biotech, Seroba Life Sciences, Genesys Capital and FACIT...
BioCentury | Feb 1, 2019
Company News

Celgene gains option for Triphase's epigenetic cancer therapy

...leukemia rearrangements leukemia and lymphoma, FACIT President David O'Neill told BioCentury. Triphase is majority-owned by FACIT...
BioCentury | Jan 29, 2019
Company News

Celgene gains option for Triphase's epigenetic cancer therapy

...leukemia rearrangements leukemia and lymphoma, FACIT President David O'Neill told BioCentury. Triphase is majority-owned by FACIT...
BioCentury | Dec 21, 2018
Clinical News

Achillion discontinuing PNH monotherapy

...said ACH-4471 monotherapy led to increases in hemoglobin and Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
...inhibitor Indication: Treat paroxysmal nocturnal hemoglobinuria (PNH) Endpoint: Hemoglobin, Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
BioCentury | Dec 19, 2018
Clinical News

Achillion down after discontinuing PNH monotherapy

...said ACH-4471 monotherapy led to increases in hemoglobin and Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
BioCentury | Jun 22, 2018
Politics & Policy

FDA lays out cancer PRO strategy

...of the Common Technology Criteria for Adverse events (CTCAE), Functional Assessment of Chronic Illness Therapy (FACIT...
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Johnson, Isogenica Ltd. Number of employees: 20 Funds raised: $46 million Investors: Adams Street Partners, FACIT...
BioCentury | Apr 27, 2018
Clinical News

Alexion's long-acting C5 inhibitor meets in Phase III switch trial

...hemolysis (0% vs. 5.1%); the change from baseline in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
...of patients with breakthrough hemolysis, change from baseline in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue...
Items per page:
1 - 10 of 67